搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Onlymyhealth
2 天
7 Natural Ways To Treat Persistent Cough
Cold, cough, and flu are common issues as the winter season approaches. It causes nasal congestion and difficulty in ...
health enews
7 天
Nasal congestion on one side? You may have this condition
A deviated septum occurs when you have two different-sized nasal passageways which can cause one-sided congestion.
Onlymyhealth
9 天
From Allergies to Asthma, These Conditions Can Trigger Nasal Polyps
often resulting from chronic inflammation. While these benign growths themselves are not harmful, they can lead to ...
Monthly Prescribing Reference
6 天
Tezepelumab Reduces Nasal Congestion and Polyp Size in Chronic Rhinosinusitis
Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and nasal congestion in adults with chronic rhinosinusitis with nasal polyps ...
Woman's World on MSN
6 天
Is Your Toothache Actually a Sinus Infection? How to Tell—and Treat It
Sinus infections (also known as sinusitis) strike more than 30 million Americans each year. And if you’re one of them, you’re ...
5 天
TEZSPIRE MET BOTH CO-PRIMARY ENDPOINTS IN PHASE 3 TRIAL FOR CHRONIC RHINOSINUSITIS WITH ...
Amgen (NASDAQ:AMGN) and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients ...
FiercePharma
5 天
AstraZeneca, Amgen's Tezspire scores in rhinosinusitis study
Six months after Amgen and AstraZeneca reported promising results for Tezspire (t | A phase 3 study has shown that ...
5 天
AstraZeneca/Amgen's Asthma Drug Aces Late-Stage Study In Patients With Chronic Rhinosinusitis
AstraZeneca Plc (NASDAQ:AZN) and Amgen Inc (NASDAQ:AMGN) released topline data from the Phase 3 WAYPOINT trial of Tezspire ...
5 天
Amgen, AstraZeneca announce top-line results from WAYPOINT trial
Amgen (AMGN) and AstraZeneca (AZN) announced top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with ...
5 天
on MSN
Amgen, AstraZeneca post Phase 3 win for nasal polyps therapy
Amgen (AMGN) and AstraZeneca's (AZN) asthma therapy Tezspire hits main goals in the Phase 3 trial for chronic rhinosinusitis ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈